Impact of Pretransplant Donor and Recipient Cytomegalovirus Serostatus On Outcome for Multiple Myeloma Patients Undergoing Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation

被引：0
|
作者：
El-Cheikh, Jean
Devillier, Raynier
Crocchiolo, Roberto
Furst, Sabine [1 ]
Calmels, Boris [2 ]
Faucher, Catherine
Stoppa, Anne Marie
Granata, Angela
Oudin, Claire
Ladaique, Patrick
Lemarie, Claude
Venton, Geoffroy
Bouabdallah, Reda
Zandotti, Christine
Berger, Pierre
Chabannon, Christian [3 ]
Blaise, Didier [4 ]
机构：
[1] Inst J Paoli I Calmettes, UTTC, F-13009 Marseille, France
[2] Inst J Paoli I Calmettes, Ctr Therapie Cellualire & Genique, F-13009 Marseille, France
[3] Inst J Paoli I Calmettes, Ctr Biol Ressources, F-13009 Marseille, France
[4] Inst J Paoli I Calmettes, Dept Hematol, Transplant Program, F-13009 Marseille, France
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.4496.4496
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4496
引用
收藏
页数：3
相关论文
共 50 条
  • [21] DONOR CHIMERISM KINETICS IN PEDIATRIC PATIENTS UNDERGOING REDUCED INTENSITY CONDITIONING (RIC) WITH ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)
    Schneiderman, J.
    Rademaker, A. W.
    Chaudry, S.
    Tse, W.
    Jacobson, D. A.
    Duerst, R.
    Kletzel, M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 83 - 83
  • [22] Allogeneic stem cell transplantation with reduced intensity conditioning for patients with adrenoleukodystrophy
    Kato, Koji
    Maemura, Ryo
    Wakamatsu, Manabu
    Yamamori, Ayako
    Hamada, Motoharu
    Kataoka, Shinsuke
    Narita, Atsushi
    Miwata, Shunsuke
    Sekiya, Yuko
    Kawashima, Nozomu
    Suzuki, Kyogo
    Narita, Kotaro
    Doisaki, Sayoko
    Muramatsu, Hideki
    Sakaguchi, Hirotoshi
    Matsumoto, Kimikazu
    Koike, Yuka
    Onodera, Osamu
    Kaga, Makiko
    Shimozawa, Nobuyuki
    Yoshida, Nao
    MOLECULAR GENETICS AND METABOLISM REPORTS, 2019, 18 : 1 - 6
  • [23] PRETRANSPLANT DONOR AND RECIPIENT CMV SEROSTATUS AND OUTCOME OF RIC ALLOGENEIC SCT FOR MULTIPLE MYELOMA IN THE ERA OF CMV PRE-EMPTIVE THERAPY
    Elcheikh, J.
    Devillier, R.
    Crocchiolo, R.
    Furst, S.
    Faucher, C.
    Stoppa, A. M.
    Granata, A.
    Oudin, C.
    Ladaique, P.
    Coso, D.
    Calmels, B.
    Lemarie, C.
    Bouabdallah, R.
    Chabannon, C.
    Balise, D.
    HAEMATOLOGICA, 2012, 97 : 715 - 715
  • [24] Role of Reduced-Intensity Conditioning Followed by Allogeneic Stem Cell Transplantation In Patients with Multiple Myeloma Relapsing After Autograft a Donor Versus No Donor Analysis.
    Patriarca, Francesca
    Einsele, Hermann
    Spina, Francesco
    Bruno, Benedetto
    Nozzoli, Chiara
    Isola, Miriam
    Sperotto, Alessandra
    Nozza, Andrea
    Morabito, Fortunato
    Stuhler, Gernot
    Festuccia, Moreno
    Bosi, Alberto
    Fanin, Renato
    Corradini, Paolo
    BLOOD, 2010, 116 (21) : 1453 - 1453
  • [25] Reduced-intensity Conditioning Allogeneic Stem Cell Transplantation in Myeloma: A Prospective Trial
    Gahrton, G.
    Bjoerkstrand, B.
    Iacobelli, S.
    Hegenbart, U.
    Gruber, A.
    Greinix, H.
    Volin, L.
    Narni, F.
    Musto, P.
    Beksac, M.
    Bosi, A.
    Milone, G.
    Corradini, P.
    Goldschmidt, H.
    de Witte, T.
    Morris, C.
    Niederwieser, D.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S9 - S10
  • [26] Impact of conditioning intensity on outcome in high-risk myelofibrosis undergoing allogeneic stem cell transplantation
    Gagelmann, N.
    Badbaran, A.
    Ditschkowski, M.
    Bogdanov, R.
    Panagiota, V
    Thol, F.
    Robin, M.
    Heuser, M.
    Beelen, D.
    Kroeger, N.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 58 - 59
  • [27] Impact of Donor Age and Donor Cytomegalovirus Serostatus on Outcomes After Related Donor Allogeneic Hematopoietic Stem Cell Transplantation
    Mehta, Rohtesh S.
    Choe, Hannah
    Saultz, Jennifer
    Gong, Zimu
    Sharma, Prashant
    Al-Juhaishi, Taha
    Petitto, Gabriela S.
    Lazaryan, Aleksandr
    Singh, Anurag
    Xue, Elisabetta
    Dimitrova, Dimana
    Hyder, Mustafa
    Mccurdy, Shannon
    Im, Annie
    Huber, Bryan
    Aljawai, Yosra M.
    Kanakry, Jennifer
    Milano, Filippo
    Kanakry, Christopher G.
    AMERICAN JOURNAL OF HEMATOLOGY, 2025,
  • [28] Reduced-Intensity Regimens for Allogeneic Stem Cell Transplantation Improve the Outcome in Advanced Multiple Myeloma
    Cole, Suzanne M.
    Saliba, Rima
    Pelosini, Matteo
    Mendoza, Floralyn L.
    Weber, Donna
    Wang, Michael
    Thomas, Sheeba
    Orlowski, Robert Z.
    Shah, Jatin
    Alousi, Amin
    Hosing, Chitra
    Popat, Uday
    Kebriaei, Partow
    Anderlini, Paolo
    Khouri, Issa F.
    Champlin, Richard
    Giralt, Sergio
    Qazilbash, Muzaffar H.
    BLOOD, 2008, 112 (11) : 1132 - 1133
  • [29] Allogeneic stem cell transplantation in MDS: reduced intensity conditioning and donor lymphocyte infusion
    Kroeger, N.
    LEUKEMIA RESEARCH, 2009, 33 : S28 - S28
  • [30] Bortezomib for relapse after reduced-intensity conditioning allogeneic haematopoietic stem cell transplantation for multiple myeloma
    Michallet, M
    Duscatelle, S
    Rafii, H
    Troncy, J
    Thiebaut, A
    Thomas, X
    Tavernier, E
    Le, QH
    Raus, N
    Praire, A
    Nicolini, F
    BONE MARROW TRANSPLANTATION, 2005, 35 : S389 - S389
12345